Delivery Order SPE2DB24D1205-SPE2DB24FCSMA
Award Date
7/5/24
Potential Completion Date
7/26/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,530.60, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a completion date of June 11, 2024. This is a firm fixed-price delivery order contract and was awarded on a full and open competition basis without any set-aside...
This federal contract award, valued at $4,530.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 24, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 firm-fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $9,061.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $11,326.45 for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of September 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
This federal contract award, with a ceiling value of $6,795.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract, which does not have a set-aside designation, is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $9,061.20 for the supply of TEZSPIRE 210 MG/1.91 ML syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen's federal contracting activities. This award is a part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,343.59, is for the delivery of the drug product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 19, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,530.60 firm fixed-price delivery order is for the medication Tezspire 210 mg/1.91 ml pen. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...